Literature DB >> 7665601

Human xeroderma pigmentosum group A protein interacts with human replication protein A and inhibits DNA replication.

S H Lee1, D K Kim, R Drissi.   

Abstract

Human replication protein A (RPA; also known as human single-stranded DNA binding protein, or HSSB) is a multisubunit complex involved in both DNA replication and repair. While the role of RPA in replication has been well studied, its function in repair is less clear, although it is known to be involved in the early stages of the repair process. We found that RPA interacts with xeroderma pigmentosum group A complementing protein (XPAC), a protein that specifically recognizes UV-damaged DNA. We examined the effect of this XPAC-RPA interaction on in vitro simian virus 40 (SV40) DNA replication catalyzed by the monopolymerase system. XPAC inhibited SV40 DNA replication in vitro, and this inhibition was reversed by the addition of RPA but not by the addition of DNA polymerase alpha-primase complex, SV40 large tumor antigen, or topoisomerase I. This inhibition did not result from an interaction between XPAC and single-stranded DNA (ssDNA), or from competition between RPA and XPAC for DNA binding, because XPAC does not show any ssDNA binding activity and, in fact, stimulates RPA's ssDNA binding activity. Furthermore, XPAC inhibited DNA polymerase alpha activity in the presence of RPA but not in RPA's absence. These results suggest that the inhibitory effect of XPAC on DNA replication probably occurs through its interaction with RPA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665601     DOI: 10.1074/jbc.270.37.21800

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner.

Authors:  N A Abramova; J Russell; M Botchan; R Li
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 2.  Other proteins interacting with XP proteins.

Authors:  Steven M Shell; Yue Zou
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

3.  Photocrosslinking locates a binding site for the large subunit of human replication protein A to the damaged strand of cisplatin-modified DNA.

Authors:  U Schweizer; T Hey; G Lipps; G Krauss
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  Roles of replication protein-A subunits 2 and 3 in DNA replication fork movement in Saccharomyces cerevisiae.

Authors:  H S Maniar; R Wilson; S J Brill
Journal:  Genetics       Date:  1997-04       Impact factor: 4.562

5.  The middle subunit of replication protein A contacts growing RNA-DNA primers in replicating simian virus 40 chromosomes.

Authors:  G Mass; T Nethanel; G Kaufmann
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

6.  TFIIH-mediated nucleotide excision repair and initiation of mRNA transcription in an optimized cell-free DNA repair and RNA transcription assay.

Authors:  M S Satoh; P C Hanawalt
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 7.  Orchestral maneuvers at the damaged sites in nucleotide excision repair.

Authors:  Sergey Alekseev; Frédéric Coin
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

8.  In vitro analysis of UV-damage-induced inhibition of replication.

Authors:  R Drissi; S H Lee
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 9.  XPA: A key scaffold for human nucleotide excision repair.

Authors:  Norie Sugitani; Robert M Sivley; Kelly E Perry; John A Capra; Walter J Chazin
Journal:  DNA Repair (Amst)       Date:  2016-05-20

10.  Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.

Authors:  Norie Sugitani; Markus W Voehler; Michelle S Roh; Agnieszka M Topolska-Woś; Walter J Chazin
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.